Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | DPP4 | P27487 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12705340 | 0.91 | ALDH1A1 (0.36) | ALDH1A1DPP4LMNANPSR1THRB | |
| SCHEMBL12256166 | 0.80 | PKM (0.38) | ALDH1A1DPP4LMNANPSR1PKM | |
| SCHEMBL686079 | 0.80 | NPSR1 (0.35) | ALDH1A1DPP4NPSR1PKMHSD11B1 | |
| SCHEMBL12705353 | 0.79 | ALDH1A1 (0.40) | ALDH1A1DPP4LMNANPSR1PKM | |
| SCHEMBL22811877 | 0.78 | THRB (0.40) | ALDH1A1DPP4NPSR1PKMHSD11B1 | |
| SCHEMBL12705244 | 0.77 | LMNA (0.46) | ALDH1A1LMNAHSD11B1 | |
| SCHEMBL787018 | 0.77 | ALDH1A1 (0.32) | ALDH1A1NPSR1 | |
| SCHEMBL2758375 | 0.75 | PKM (0.41) | ALDH1A1DPP4LMNANPSR1PKM | |
| SCHEMBL13613924 | 0.75 | PKM (0.41) | ALDH1A1DPP4NPSR1PKMHSD11B1 | |
| SCHEMBL685887 | 0.75 | ALDH1A1 (0.35) | ALDH1A1LMNANPSR1HSD11B1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110091808-A1 | PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110091808-A1 | PHOTORESIST COMPOSITION | ASIC1, ASIC3, SUN2 | ALDH1A1 2111/4885DPP4 4646/4885LMNA 3534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.